001     271721
005     20240908004716.0
024 7 _ |a 10.1038/s41467-024-51310-z
|2 doi
024 7 _ |a pmid:39174524
|2 pmid
024 7 _ |a pmc:PMC11341845
|2 pmc
024 7 _ |a altmetric:166589576
|2 altmetric
037 _ _ |a DZNE-2024-01073
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Banks, Emily
|0 0000-0001-9908-1151
|b 0
245 _ _ |a Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy.
260 _ _ |a [London]
|c 2024
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1725442414_24435
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Developmental and epileptic encephalopathies (DEEs) feature altered brain development, developmental delay and seizures, with seizures exacerbating developmental delay. Here we identify a cohort with biallelic variants in DENND5A, encoding a membrane trafficking protein, and develop animal models with phenotypes like the human syndrome. We demonstrate that DENND5A interacts with Pals1/MUPP1, components of the Crumbs apical polarity complex required for symmetrical division of neural progenitor cells. Human induced pluripotent stem cells lacking DENND5A fail to undergo symmetric cell division with an inherent propensity to differentiate into neurons. These phenotypes result from misalignment of the mitotic spindle in apical neural progenitors. Cells lacking DENND5A orient away from the proliferative apical domain surrounding the ventricles, biasing daughter cells towards a more fate-committed state, ultimately shortening the period of neurogenesis. This study provides a mechanism for DENND5A-related DEE that may be generalizable to other developmental conditions and provides variant-specific clinical information for physicians and families.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Membrane Proteins
|2 NLM Chemicals
650 _ 7 |a Guanine Nucleotide Exchange Factors
|2 NLM Chemicals
650 _ 2 |a Neural Stem Cells: metabolism
|2 MeSH
650 _ 2 |a Neural Stem Cells: cytology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Cell Division
|2 MeSH
650 _ 2 |a Induced Pluripotent Stem Cells: metabolism
|2 MeSH
650 _ 2 |a Induced Pluripotent Stem Cells: cytology
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Neurogenesis: genetics
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Membrane Proteins: metabolism
|2 MeSH
650 _ 2 |a Membrane Proteins: genetics
|2 MeSH
650 _ 2 |a Guanine Nucleotide Exchange Factors: metabolism
|2 MeSH
650 _ 2 |a Guanine Nucleotide Exchange Factors: genetics
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Cell Polarity
|2 MeSH
700 1 _ |a Francis, Vincent
|b 1
700 1 _ |a Lin, Sheng-Jia
|0 0000-0002-7559-6529
|b 2
700 1 _ |a Kharfallah, Fares
|b 3
700 1 _ |a Fonov, Vladimir
|0 0000-0003-3402-7749
|b 4
700 1 _ |a Lévesque, Maxime
|0 0000-0002-1593-7037
|b 5
700 1 _ |a Han, Chanshuai
|b 6
700 1 _ |a Kulasekaran, Gopinath
|b 7
700 1 _ |a Tuznik, Marius
|b 8
700 1 _ |a Bayati, Armin
|0 0000-0002-5960-0479
|b 9
700 1 _ |a Al-Khater, Reem
|0 0000-0002-7965-2532
|b 10
700 1 _ |a Alkuraya, Fowzan S
|0 0000-0003-4158-341X
|b 11
700 1 _ |a Argyriou, Loukas
|b 12
700 1 _ |a Babaei, Meisam
|b 13
700 1 _ |a Bahlo, Melanie
|0 0000-0001-5132-0774
|b 14
700 1 _ |a Bakhshoodeh, Behnoosh
|b 15
700 1 _ |a Barr, Eileen
|0 0000-0002-6330-4680
|b 16
700 1 _ |a Bartik, Lauren
|b 17
700 1 _ |a Bassiony, Mahmoud
|0 0000-0002-7690-8029
|b 18
700 1 _ |a Bertrand, Miriam
|b 19
700 1 _ |a Braun, Dominique
|0 0000-0002-4340-4334
|b 20
700 1 _ |a Buchert, Rebecca
|0 0000-0001-7576-3326
|b 21
700 1 _ |a Budetta, Mauro
|b 22
700 1 _ |a Cadieux-Dion, Maxime
|b 23
700 1 _ |a Calame, Daniel G
|b 24
700 1 _ |a Cope, Heidi
|b 25
700 1 _ |a Cushing, Donna
|b 26
700 1 _ |a Efthymiou, Stephanie
|0 0000-0003-4900-9877
|b 27
700 1 _ |a Elmaksoud, Marwa Abd
|0 0000-0001-5827-4459
|b 28
700 1 _ |a El Said, Huda G
|b 29
700 1 _ |a Froukh, Tawfiq
|0 0000-0002-2862-0733
|b 30
700 1 _ |a Gill, Harinder K
|b 31
700 1 _ |a Gleeson, Joseph G
|0 0000-0002-0889-9220
|b 32
700 1 _ |a Gogoll, Laura
|b 33
700 1 _ |a Goh, Elaine S-Y
|0 0000-0002-2477-1665
|b 34
700 1 _ |a Gowda, Vykuntaraju K
|0 0000-0001-7244-0492
|b 35
700 1 _ |a Haack, Tobias B
|0 0000-0001-6033-4836
|b 36
700 1 _ |a Hashem, Mais O
|b 37
700 1 _ |a Hauser, Stefan
|0 P:(DE-2719)2810998
|b 38
700 1 _ |a Hoffman, Trevor L
|b 39
700 1 _ |a Hogue, Jacob S
|b 40
700 1 _ |a Hosokawa, Akimoto
|b 41
700 1 _ |a Houlden, Henry
|0 0000-0002-2866-7777
|b 42
700 1 _ |a Huang, Kevin
|0 0000-0002-2512-7812
|b 43
700 1 _ |a Huynh, Stephanie
|b 44
700 1 _ |a Karimiani, Ehsan G
|b 45
700 1 _ |a Kaulfuß, Silke
|b 46
700 1 _ |a Korenke, G Christoph
|b 47
700 1 _ |a Kritzer, Amy
|b 48
700 1 _ |a Lee, Hane
|0 0000-0002-4736-0412
|b 49
700 1 _ |a Lupski, James R
|0 0000-0001-9907-9246
|b 50
700 1 _ |a Marco, Elysa J
|b 51
700 1 _ |a McWalter, Kirsty
|0 0000-0002-1654-9036
|b 52
700 1 _ |a Minassian, Arakel
|b 53
700 1 _ |a Minassian, Berge A
|b 54
700 1 _ |a Murphy, David
|b 55
700 1 _ |a Neira-Fresneda, Juanita
|b 56
700 1 _ |a Northrup, Hope
|0 0000-0002-2892-0840
|b 57
700 1 _ |a Nyaga, Denis M
|0 0000-0001-6240-4017
|b 58
700 1 _ |a Oehl-Jaschkowitz, Barbara
|b 59
700 1 _ |a Osmond, Matthew
|b 60
700 1 _ |a Person, Richard
|b 61
700 1 _ |a Pehlivan, Davut
|b 62
700 1 _ |a Petree, Cassidy
|b 63
700 1 _ |a Sadleir, Lynette G
|b 64
700 1 _ |a Saunders, Carol
|0 0000-0002-7407-7735
|b 65
700 1 _ |a Schoels, Ludger
|0 P:(DE-2719)2810795
|b 66
|u dzne
700 1 _ |a Shashi, Vandana
|b 67
700 1 _ |a Spillmann, Rebecca C
|b 68
700 1 _ |a Srinivasan, Varunvenkat M
|b 69
700 1 _ |a Torbati, Paria N
|b 70
700 1 _ |a Tos, Tulay
|b 71
700 1 _ |a Network, Undiagnosed Diseases
|b 72
|e Collaboration Author
700 1 _ |a Zaki, Maha S
|0 0000-0001-7840-0002
|b 73
700 1 _ |a Zhou, Dihong
|b 74
700 1 _ |a Zweier, Christiane
|0 0000-0001-8002-2020
|b 75
700 1 _ |a Trempe, Jean-François
|0 0000-0002-6543-3371
|b 76
700 1 _ |a Durcan, Thomas M
|b 77
700 1 _ |a Gan-Or, Ziv
|0 0000-0003-0332-234X
|b 78
700 1 _ |a Avoli, Massimo
|b 79
700 1 _ |a Alves, Cesar
|b 80
700 1 _ |a Varshney, Gaurav K
|0 0000-0002-0429-1904
|b 81
700 1 _ |a Maroofian, Reza
|0 0000-0001-6763-1542
|b 82
700 1 _ |a Rudko, David A
|b 83
700 1 _ |a McPherson, Peter S
|0 0000-0001-7806-5662
|b 84
700 1 _ |a Cope, Heidi
|b 85
|e Contributor
773 _ _ |a 10.1038/s41467-024-51310-z
|g Vol. 15, no. 1, p. 7239
|0 PERI:(DE-600)2553671-0
|n 1
|p 7239
|t Nature Communications
|v 15
|y 2024
|x 2041-1723
856 4 _ |u https://pub.dzne.de/record/271721/files/DZNE-2024-01073%20SRC.xlsx
856 4 _ |u https://pub.dzne.de/record/271721/files/DZNE-2024-01073%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/271721/files/DZNE-2024-01073.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/271721/files/DZNE-2024-01073.pdf?subformat=pdfa
856 4 _ |u https://pub.dzne.de/record/271721/files/DZNE-2024-01073%20SRC.csv
856 4 _ |u https://pub.dzne.de/record/271721/files/DZNE-2024-01073%20SRC.ods
856 4 _ |u https://pub.dzne.de/record/271721/files/DZNE-2024-01073%20SRC.xls
909 C O |o oai:pub.dzne.de:271721
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 38
|6 P:(DE-2719)2810998
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 66
|6 P:(DE-2719)2810795
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-29
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-29
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2023-08-29
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-29
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:09:09Z
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-29
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls
|l Clinical Neurogenetics
|x 0
920 1 _ |0 I:(DE-2719)1210016
|k AG Hauser
|l Advanced cellular models of neurodegeneration
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000005
980 _ _ |a I:(DE-2719)1210016
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21